INS and type 2 diabetes mellitus: Similarly, another study showed that the addition of pioglitazone to metformin-treated type 2 diabetic patients decreased HbA1c and HOMA-IR42 as well as fasting insulin concentrations as compared with the sulfonylurea plus metformin group59.